Fig. 3. Human liver tissue seed graft function.

Slides:



Advertisements
Similar presentations
Fig. 5. Pharmacological JAK2 inhibition in vivo abrogates tumor-initiating potential after chemotherapy. Pharmacological JAK2 inhibition in vivo abrogates.
Advertisements

Fig. 5. Vascularization of human liver seed grafts.
Therapeutic effects of TIP60 allosteric modification in DSS-induced colitis. Therapeutic effects of TIP60 allosteric modification in DSS-induced colitis.
Splenic CD169+ macrophages express a unique gene profile.
LV activation of DCs and subsequent CD8+ T cell priming are dependent on STING and cGAS but not on MyD88, TRIF, or MAVS. LV activation of DCs and subsequent.
Increased resistance of GPR55-deficient mice to indomethacin-induced intestinal permeability. Increased resistance of GPR55-deficient mice to indomethacin-induced.
Fig. 7 Correlation of NHP and human ISGs.
T-bethi MP cells produce IFN-γ in response to IL-12.
Differentiation of AZD4785 from MAPK pathway inhibitors in vitro
Fig. 6 In utero injection of inflammatory cytokines or adoptive transfer of activated T cells leads to pregnancy loss. In utero injection of inflammatory.
Fig. 5 Hypoxic tumors from obese mice associate with increased production of IL-6 by adipocytes and myeloid cells. Hypoxic tumors from obese mice associate.
Fig. 2 AcPGP induces IL-8 and G-CSF release from human bronchial epithelial cells. AcPGP induces IL-8 and G-CSF release from human bronchial epithelial.
Cell viability tests. Cell viability tests. SEM images of (A) MC3T3-E1 cells and (B) MSCs on days 1, 3, and 5 of culture. (C) Survival rates of MC3T3-E1.
Fig. 5. Microarray analysis of tumors treated by dabrafenib, trametinib, or the combination of dabrafenib and trametinib with pmel-1 ACT or mock ACT. Microarray.
Fig. 1. MSCs undergo in vivo apoptosis after infusion without affecting immunosuppression. MSCs undergo in vivo apoptosis after infusion without affecting.
Fig. 3 M7824 inhibits tumor growth and metastasis and provides long-term antitumor immunity. M7824 inhibits tumor growth and metastasis and provides long-term.
Fig. 5 A competent Fc is required for the antitumor immune response.
Fig. 6. Nontaxane chemotherapies induce TMEM-dependent prometastatic changes in the breast cancer microenvironment. Nontaxane chemotherapies induce TMEM-dependent.
Fig. 3 Liver stiffness and NT-proBNP concentration after treatment with miridesap followed by dezamizumab. Liver stiffness and NT-proBNP concentration.
In vivo release of doxycycline hyclate from the GRS in a swine model
Fig. 1 AVPR1A is regulated by the AR coactivator VAV3 and AR-V7 and is increased in advanced human PC. AVPR1A is regulated by the AR coactivator VAV3 and.
Fig. 8 Combining M7824 with radiation or chemotherapy enhances antitumor efficacy. Combining M7824 with radiation or chemotherapy enhances antitumor efficacy.
Fig. 5. In vivo characterization of adipogenesis by CT.
Fig. 1. Potent and selective down-regulation of KRAS mRNA and protein by AZD4785 in vitro and in vivo. Potent and selective down-regulation of KRAS mRNA.
Fig. 3. Increased expression of exhaustion markers and apoptosis markers on CAR8 cells in the presence of TCR antigen. Increased expression of exhaustion.
Fig. 1. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy.
Fig. 4 Administration of BMS to mice inhibits autoimmune-relevant pharmacodynamic endpoints driven by IL-12 and IFNα. Administration of BMS
Fig. 7 BMS reduces the elevated expression of type I IFN–regulated genes both ex vivo in blood from patients with lupus and in a phase 1 study of.
Fig. 2 In situ vaccination of CpG in combination with anti-OX40 antibody cures established local and distant tumors. In situ vaccination of CpG in combination.
BMS blocks functional responses in primary immune cells driven by IFNα
Fig. 2. Effects of SFN in mouse hepatocytes and in rat models of diet-induced glucose intolerance. Effects of SFN in mouse hepatocytes and in rat models.
Fig. 5 Treatment with BMS (PO BID) protects from wasting and colitis in two SCID mouse models. Treatment with BMS (PO BID) protects from.
Fig. 3 Treating vaccinated mice with OVA-releasing scaffolds enhances angiogenesis and muscle regeneration following ischemic injury. Treating vaccinated.
Fig. 6 RUNX/CBFB interaction inhibitor, Ro5-3335, significantly decreases mouse neurofibroma growth in vivo. RUNX/CBFB interaction inhibitor, Ro5-3335,
Human pluripotent stem cell–derived erythropoietin-producing cells ameliorate renal anemia in mice by Hirofumi Hitomi, Tomoko Kasahara, Naoko Katagiri,
Fig. 1 IDH3α expression is elevated in human-derived gliomas.
Fig. 5 n-HA regulates gene expressions related to tumor suppression, calcium homeostasis, and immune response. n-HA regulates gene expressions related.
Fig. 1. Matrix stiffness sensitizes myofibroblasts to apoptosis induced by inhibition of their mechanotransduction pathways. Matrix stiffness sensitizes.
Fig. 3 Local Maraba treatment of TNBC tumors provides long-term systemic protection. Local Maraba treatment of TNBC tumors provides long-term systemic.
Nanoimmunotherapy production scale-up and evaluation in Apoe−/− mice
Fig. 1. The HCN channel blocker ivabradine (IVA) is analgesic in a mouse model of type 1 diabetes. The HCN channel blocker ivabradine (IVA) is analgesic.
PD and efficacy of AZD4785 in KRAS mutant lung cancer xenograft models
Pharmacological targeting of CDs promotes response to KRASG12C inhibition in vivo. Pharmacological targeting of CDs promotes response to KRASG12C inhibition.
Fig. 2. PlGF-2123–144 conjugation reduces systemic exposure to checkpoint blockade Abs and potential treatment-related toxicity. PlGF-2123–144 conjugation.
GPR55 regulates γδT cell egress from PP and homing of gut-tropic CD8 T cells to the small intestine. GPR55 regulates γδT cell egress from PP and homing.
Fig. 4 Dox-CBD-SA treatment shows reduced toxicity.
Fig. 5. Vascularization of human liver seed grafts.
Tissue architecture affects function of expanded liver seed grafts
Targeting p53-dependent stem cell loss for intestinal chemoprotection
Fig. 3 Mmp-2−/− mice are protected from obesity and leptin resistance.
Fig. 2 Neonatal ZIKV infection induces seizures in young mice and increases susceptibility to chemically induced seizures in adult mice. Neonatal ZIKV.
Fig. 5 Increased myometrial cell contractility in response to fetal T cells from preterm infants. Increased myometrial cell contractility in response to.
Fig. 6 Antitumor effect on tumor growth and pulmonary metastasis of CSSD-9 in vivo. Antitumor effect on tumor growth and pulmonary metastasis of CSSD-9.
In vivo prophylactic and therapeutic efficacy of C12G6 in mice
Fig. 2. Human liver tissue seed grafts expand after host liver injury.
Fig. 1. GDF15 is up-regulated with obesity, and AAV-GDF15 improves metabolic parameters in DIO mice. GDF15 is up-regulated with obesity, and AAV-GDF15.
Fig. 8. TIE2 inhibitor rebastinib eliminates the prometastatic effects of paclitaxel. TIE2 inhibitor rebastinib eliminates the prometastatic effects of.
Effects of highly concentrated SFN provided as BSE in T2D patients
Fig. 3 Effects of ASO and eGLP1-ASO conjugates on gene expression and protein levels in vitro in cell lines and primary mouse islet cells. Effects of ASO.
Fig. 1. Construction of human liver seed grafts.
Fig. 7 BEL immune response.
Fig. 6. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex vivo. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex.
Fig. 3. Paclitaxel promotes TMEM-dependent vascular permeability, cancer cell dissemination, and metastasis in breast cancer. Paclitaxel promotes TMEM-dependent.
ATP analogs have little effect on the conformation of the 2CARD domain
Fig. 1 Differentiation of human peripheral blood monocytes into MDMi cells induces a microglial gene expression and functional phenotype. Differentiation.
Fig. 6 TNF-α neutralization prevents ZIKV-induced seizures in mice.
Fig. 6 Pharmacologic alterations of β-AR signaling regulate cardiomyocyte abscission and endowment. Pharmacologic alterations of β-AR signaling regulate.
Fig. 8 Immune correlates of protection.
In vivo function of MeTro sealants using rat incision model of lungs
Fig. 3. Effects of SFN in mice with diet-induced diabetes.
Presentation transcript:

Fig. 3. Human liver tissue seed graft function. Human liver tissue seed graft function. Mice were implanted with liver seed grafts, and the host mice were treated intermittently with NTBC to induce liver injury and repair (14 days off, followed by 3 to 4 days on; gray bars). (A) Blood samples were collected weekly by retro-orbital bleeding. The concentration of human albumin in mouse serum was greater in animals with liver injury compared to controls [P < 0.0001, one-way analysis of variance (ANOVA)]. (B) Human albumin concentration for each animal averaged across all time points. (C) The concentrations of human transferrin, α1-antitrypsin, and fibronectin in mouse serum were greater in animals receiving intermittent NTBC treatment (liver injury) compared to controls at 80 days after implantation into FNRG mice. (D) mRNA expression analysis of explanted liver seed grafts demonstrated that 47 of 50 liver-specific genes were expressed in explanted liver seed grafts (denoted “Seed graft”) compared to 18 of 50 human genes expressed in HUVEC and NHDF cell lines. (E and F) Genes from each of the major hepatic drug metabolism pathways were expressed in liver seed grafts at levels similar to those of the human liver. (G and H) Mice with liver seed grafts were injected with rifampin solution (25 mg/kg, intraperitoneally) or vehicle control daily for 3 days and, again, 1 hour before sacrifice. (I) Rifampin induced greater CYP3A4 expression in expanded liver seed grafts compared to mice injected with vehicle control. *P < 0.05, ***P < 0.001 (Student’s t test). Kelly R. Stevens et al., Sci Transl Med 2017;9:eaah5505 Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works